Market Cap: $64.06M
SI
Spero Therapeutics, Inc.
SPRO
NASDAQ (NASDAQ Global Select)USD
Market Cap: $64.06M
Strategic Acquisition to Enhance SAP Solutions in Agribusiness In a significant move to bolster its presence in the agribusiness sector, NTT DATA Business Solutions announces its agreement to acquire…
NTT DATA Expands Agribusiness Capabilities Through SPRO Acquisition NTT DATA Business Solutions, a leading global IT service provider specializing in SAP solutions, announces its intent to acquire SPR…
NTT DATA's Strategic Acquisition to Strengthen SAP Offerings in Brazilian Agribusiness On December 3, 2025, NTT DATA Business Solutions announces its agreement to acquire SPRO IT Solutions, a leading…
Spero Therapeutics Gears Up for Key Earnings Report Amid Focus on Antibiotic Innovation Spero Therapeutics is on the cusp of releasing its quarterly earnings report on November 13, 2025, a development…
Spero Therapeutics Gears Up for Key Earnings Report Amidst Focus on Antibiotic Innovation Spero Therapeutics is poised to release its quarterly earnings report on November 13, 2025, a significant even…
Spero Therapeutics Gears Up for Key Earnings Report Amidst Pipeline Developments Spero Therapeutics is set to release its quarterly earnings report on August 12, 2025, a moment that holds significant…
Promising Results from PIVOT-PO Trial Signal Potential Breakthrough for Tebipenem HBr Spero Therapeutics Inc., in collaboration with GSK plc, announces a significant milestone in the development of te…
Promising Efficacy Results Propel Tebipenem HBr Trial Forward Spero Therapeutics and GSK plc announce a significant milestone in the fight against complicated urinary tract infections (cUTIs) with the…